|
|
|
7 Reasons To Start Up With an Exercise Program
Most of us need to follow an exercise program. This is due to the fact that just a minority of Americans exercise in a significant way. Below follows 7 good reasons to start exercising now.
1. Contributes to fat loss.
It is well documented...
Choosing Our Parents
There's a Native American belief that before we are born, we choose our parents. It actually ties in pretty nicely with the reincarnation idea that we prearrange certain circumstances before each life so as to learn different lessons. Either...
Natural Approaches to Menopause
This past July,a report raised serious new concerns for the six million women taking combination hormone replacement therapy. In the lastest and statistically most valid study of this subject ever done,it was found that the combination of ESTROGEN...
Radiation: Too Much of a Good Thing
Radiation is wacky. We spend half our lives being terrified of it, and the other half rushing to the hospital to be voluntarily exposed to it. We're frightened at the thought of dirty nuclear bombs and concerned about too much exposure to medical...
Which Self Help Group is Right For You?
Are you going through a tough time in your life? Do you feel like you’re all alone with your problem?
Chances are that there are a lot of other people who are facing a similar difficulty right now, perhaps even other people in your own...
|
|
| |
|
|
|
|
Side Effects of Prempro - Who is Responsible for them?
Who is responsible for damages from the side-effects of Prempro?
Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), is responsible for the predominance of the side-effects of Prempro and the injuries being pursued in Prempro litigation. Menopausal and postmenopausal women have been repeatedly and erroneously over prescribed by their physicians indicating that Prempro should be taken indefinitely. Inappropriate Prempro labeling that failed to fully describe the side-effects of Prempro and long-term dosage has created many serious and life threatening health risks for women. It is the responsibility of the drug manufacturer to protect women from harmful Prempro injury and to warn of the side effects of Prempro.
Prempro litigation began after an article published in the Journal of the American Medical Association (AMA) revealed that the side-effects of Wyeth's Prempro included increased risk of probable dementia in postmenopausal women 65 years or older.
The Women's Health Initiative (WHI) Memory Study enrolled 4,532 postmenopausal women free of probable dementia aged 65 years or older. Participants received either one daily Prempro tablet or a matching placebo in a randomized, double-blind, placebo-controlled clinical trial.
The results of the memory study showed the following side-effects of Prempro: 66 percent of the 61 women diagnosed with probable dementia were receiving Prempro. This staggering statistic gave an increased risk of an additional 23 cases of dementia per 10,000 women per year. Additionally, the results coupled with previously reported Women's Health Initiative data
suggest that the risks of Prempro injury outweigh the benefits. As such, this study has been central to describing the side-effects of Premprto that are at the heart of the Prempro litigation.
Alzheimer's disease (AD), the most common form of dementia, is thought to affect 10 percent of adults over 65 years old, with women at greater risk. One theory is that lower levels of estrogen may increase the risks of dementia in postmenopausal women. Numerous studies suggest that women taking HRT have less risk of dementia.
However, the vast majority of studies have failed to separate the use of estrogen alone and estrogen plus progestin and these latest results appear to contradict earlier findings. This raises the question as to which component of the drug is responsible for the side-effects of Prempro, such as increasing the risk of dementia. This debate is being played out in the courtrooms handling litigation involving the side-effects of Prempro.
Prempro has also previously come under fire following the termination of the WHI long-term study because of increased ovarian cancer risks, heart attacks, and strokes. Further investigation into the association of estrogen therapies and dementia is now warranted.
Monheit Law is investigating Prempro Cancer cases for long term users of Prempro who have developed either breast or ovarian cancer.
See: http://www.monheit.com/prempro/responsible.shtml
About the Author
Monheit Law is investigating Prempro Cancer cases for long term users of Prempro who have developed either breast or ovarian cancer.
|
|
|
|
|
|